Groundbreaking ceremony of the small volume sterile drug factory project and the inauguration ceremony of the cancer treatment drug factory

On the morning of December 2, 2023, the Investor - Binh Dinh Pharmaceutical - Medical Equipment Joint Stock Company (Bidiphar) solemnly held the Groundbreaking Ceremony of the Small Volume Sterile Medicine Factory Project and the Ceremony. Inauguration of the Cancer Treatment Drug Factory in Area A, Nhon Hoi Economic Zone, City. Quy Nhon, Binh Dinh province.

Attending the groundbreaking and inauguration ceremony were Mr. Do Xuan Tuyen - Permanent Deputy Minister of Health, Mr. Lam Hai Giang - Vice Chairman of Binh Dinh Provincial People's Committee, Dr. Nguyen Quan - Former Member of the Party Central Committee, Former Minister of Science and Technology, Ms. Pham Thi Thanh Huong - General Director of Bidiphar, representative of Sagen design consulting unit: Mr. Thai Doan Dang - Technical Director and partners and guests. The ceremony took place in a solemn, exciting and joyful atmosphere, marking a lucky start.

Photos at the groundbreaking ceremony

Photos at the inauguration ceremony

Mr. Do Xuan Tuyen - Permanent Deputy Minister of Health spoke at the ceremony

Mr. Lam Hai Giang - Vice Chairman of Binh Dinh Provincial People's Committee spoke at the ceremony

Located in Nhon Hoi Economic Zone, the cancer treatment drug factory of Binh Dinh Pharmaceutical - Medical Equipment Joint Stock Company (Bidiphar) is on an area of 1.5 hectares with a total investment of more than 500 billion copper. The factory is invested in fully automatic, self-contained equipment and applies modern pharmaceutical production technologies that have been put into use.

The small volume sterile medicine factory alone has a total construction area of 4000m2, with 01 production basement, 01 backup production floor, 02 technical floors, auxiliary area and garage area. Construction is expected to be completed and put into use in 2027.

With the importance of the project as well as design requirements that meet modern technical standards and a closed, continuous production line from input to finished products, the Investor believes thought of choosing Sagen as the design consultant for the project. Sagen with more than 20 years of in-depth experience in the field of design consulting, especially in the Food - Pharmaceutical industry, has been building a strong and reputable brand. This project once again affirms Sagen's position as well as strengthens the sustainable cooperative relationship between the two parties in the future. Sagen is committed to bringing optimization, efficiency, safety, quality, on schedule and ensuring that it meets the Investor's requirements as well as complying with the law.


Perspective of the factory producing cancer treatment drugs

Perspective of the current Bidiphar factory